STAT editors and reporters review the widespread impact of grant cuts, layoffs and policy changes — and also discuss recent ...

Investors often view Pharmaceutical stocks as safe havens during periods of market turbulence. Indeed, shares of the three ...

Eli Lilly CEO Dave Ricks urged the Trump administration to move fast on foreign trade ... But he warned an expansion on tariffs or retaliatory tariffs would have a negative impact on not just Lilly ...

The package revives President Donald Trump’s much-maligned Most Favored Nation rule but goes further into the private markets ...

Trump's Department of Commerce is looking into what it calls national security threats from overseas drug manufacturing, and ...

US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

Global pharmaceutical shares are slumping Monday after President Donald Trump said he is looking to slash the price of ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

Johnson & Johnson factored roughly $400 million into its 2025 guidance to account for the impact ... the Trump administration could unleash an even bigger threat than tariffs to AbbVie, Lilly ...

President Trump recently warned big drugmakers that ... the president warned that a "tariff wall" is coming. Although AbbVie, Eli Lilly, and Johnson & Johnson manufacture many of their products ...